Gold Complexes in Anticancer Therapy: From New Design Principles to Particle-Based Delivery Systems

Angew Chem Int Ed Engl. 2023 May 22;62(22):e202218000. doi: 10.1002/anie.202218000. Epub 2023 Mar 15.

Abstract

The discovery of the medicinal properties of gold complexes has fuelled the design and synthesis of new anticancer metallodrugs, which have received special attention due to their unique modes of action. Current research in the development of gold compounds with therapeutic properties is predominantly focused on the molecular design of drug leads with superior pharmacological activities, e.g., by introducing targeting features. Moreover, intensive research aims at improving the physicochemical properties of gold compounds, such as chemical stability and solubility in the physiological environment. In this regard, the encapsulation of gold compounds in nanocarriers or their chemical grafting onto targeted delivery vectors could lead to new nanomedicines that eventually reach clinical applications. Herein, we provide an overview of the state-of-the-art progress of gold anticancer compounds, andmore importantly we thoroughly revise the development of nanoparticle-based delivery systems for gold chemotherapeutics.

Keywords: Anticancer; Gold Compounds; Nano-Formulation; Nanomedicine; Nanoparticles.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / chemistry
  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Drug Delivery Systems
  • Gold / chemistry
  • Gold Compounds / chemistry
  • Humans
  • Nanomedicine
  • Nanoparticles*
  • Neoplasms* / drug therapy
  • Pharmaceutical Preparations

Substances

  • Antineoplastic Agents
  • Gold
  • Pharmaceutical Preparations
  • Gold Compounds